Showing results (1-10 of 174) with videos related to
Sort By:
Pageof 18
Journal of Bone Oncology|December 29, 2018
Osteoblast suppression in multiple myeloma bone diseaseJuraj Adamik, Deborah L Galson, G David RoodmanJBMR Plus|March 29, 2019
Epigenetic-Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone DiseaseJuraj Adamik, G David Roodman, Deborah L GalsonJournal of Bone Metabolism|July 16, 2014
Pathobiology of Paget's Disease of BoneDeborah L Galson, G David RoodmanFrontiers in Endocrinology|July 17, 2018
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation SuppressionJuraj Adamik, Rebecca Silbermann, Silvia Marino, et al.Bonekey Reports|August 17, 2013
Mechanisms of multiple myeloma bone diseaseDeborah L Galson, Rebecca Silbermann, G David RoodmanMolecular Cancer Research : MCR|January 26, 2017
EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast DifferentiationJuraj Adamik, Shunqian Jin, Quanhong Sun, et al.Experimental Hematology|July 5, 2011
Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cellsFeng-Ming Wang, Deborah L Galson, G David Roodman, et al.Frontiers in Endocrinology|July 5, 2018
The Role of Semaphorin 4D in Bone Remodeling and Cancer MetastasisKonstantinos Lontos, Juraj Adamik, Anastasia Tsagianni, et al.Blood|January 7, 2012
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironmentSonia D'Souza, Noriyoshi Kurihara, Yusuke Shiozawa, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 6, 2019
EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic TargetsJuraj Adamik, Sree H Pulugulla, Peng Zhang, et al.Pageof 18